Psoroptes Ovis (Sheep Scab Mite): Notifiable Disease, Not Human Allergy

No — Psoroptes ovis and Sarcoptes scabiei (human scabies) are distinct mites with different biology and clinical profiles. P. ovis is a surface-feeding mite adapted to sheep that does not burrow — it feeds by piercing the skin surface and extracting tissue fluids. Sarcoptes scabiei is a burrowing mite that creates tunnels 2-3 mm deep in the stratum corneum of human (and animal) skin. P. ovis does not establish in humans; S. scabiei has human-adapted variants that do. P. ovis has no characterized human allergens; S. scabiei has six WHO/IUIS-characterized allergens. The diseases they cause in their respective hosts — sheep scab and human scabies — are clinically similar in presentation (intense pruritus, skin lesions) but caused by fundamentally different parasitic mechanisms.

Sheep scab is notifiable because it spreads rapidly, causes severe animal suffering, and has significant economic consequences for the sheep industry at regional and national levels. In the UK, the Animal and Plant Health Agency (APHA) manages sheep scab surveillance because the disease can spread from farm to farm through shared grazing, movement of animals, and contaminated equipment — making individual farm control insufficient. Notifiability allows authorities to conduct epidemiological tracing of outbreak sources, impose movement controls to limit spread, mandate treatment of identified cases, and coordinate regional eradication programs. The legal obligation to report removes the incentive for farmers to quietly treat and move on without containing the spread.

P. ovis is primarily adapted to sheep, but cross-species infestation does occur. Cattle can develop transient infestation from contact with heavily infested sheep, and goats are susceptible. The mite variant from sheep may not establish as persistently in cattle or goats as species-adapted Chorioptes or Sarcoptes variants, but the risk of transient spread in mixed-species farming operations is real. For regulatory purposes, sheep scab concerns are primarily sheep-to-sheep transmission, but biosecurity measures for mixed operations should include separating sheep from cattle and goats during a confirmed sheep scab outbreak.

Sheep scab can progress with alarming speed. In heavily infested conditions — typical of autumn housing — a single affected animal can spread the mite to the entire flock within 2-4 weeks. Individual animal disease progression from initial pruritus to extensive wool loss and skin crusting can occur within 4-6 weeks in susceptible animals. Untreated animals deteriorate from there through secondary bacterial infection of damaged skin, profound weight loss, and death in severe cases within 2-4 months. The intense pruritus causes constant behavioral disturbance — affected sheep spend most of their time rubbing and biting at lesions rather than feeding, compounding the welfare and production impact.

Human infestation with Psoroptes ovis is extremely rare — the medical literature contains only a handful of case reports, all involving prolonged intense contact with heavily affected animals. In the vast majority of farm worker contacts with scab-affected sheep, any mites that transfer to human skin fail to establish and cause only a transient, mild pruritic reaction that resolves within days without treatment. P. ovis is highly adapted to sheep skin physiology and cannot complete its lifecycle on human hosts. This is fundamentally different from Sarcoptes scabiei, where the animal-adapted variant (var. canis from dogs, for example) can temporarily infest humans more readily.

Organophosphate plunge dipping effectively treats the sheep — killing mites on the animals being dipped — and thereby reduces the mite burden available to transfer to farm workers. However, the dipping process itself, particularly manual immersion and control of sheep in the dip bath, involves intensive contact with the infested animals at the highest-mite-burden moment just before the dip kills them. Full PPE (waterproof coveralls, chemical-resistant gloves, face shield) is essential during dipping operations both for mite contact protection and because organophosphate chemicals in the dip bath are hazardous to humans if absorbed through skin or inhaled. The PPE itself is the worker protection — the dip is the animal treatment.

Both are common external parasite conditions of sheep causing pruritus and wool damage, but they are caused by different organisms with different treatments. Sheep scab is caused by the mite Psoroptes ovis — an eight-legged arachnid. Sheep lice (Bovicola ovis, the biting louse) are six-legged insects. Macrocyclic lactones (ivermectin, moxidectin) are highly effective against sheep scab (mites) but have little or no efficacy against sucking lice and variable efficacy against biting lice. Organophosphate dips treat both mites and lice. Pyrethroids are effective against lice but less reliable for mites. Correct differential diagnosis through microscopic examination of skin scrapings or louse identification guides appropriate treatment selection.

Early sheep scab can be subtle and easily missed. The first sign is usually one or more sheep showing increased pruritic behavior: nibbling or biting at the back and sides, frequently rubbing against fence posts or feed troughs, wool pulling, and general restlessness. Careful examination of these animals reveals early lesions — most commonly on the shoulders, back, and flanks — as small areas of moist, matted wool with slight reddening of the skin below. Skin scraping microscopy from the active lesion edge (where mites concentrate at the advancing front) confirms P. ovis. Early detection and prompt whole-flock treatment before extensive lesion development dramatically improves treatment outcomes and reduces welfare impact.

Ivermectin resistance in Psoroptes ovis is an emerging concern in some sheep-producing regions — particularly where ivermectin has been used as the sole active ingredient for many years. Reports of apparent treatment failure with ivermectin-based products for sheep scab have been documented in the UK and several European countries. Long-acting moxidectin formulations retain better efficacy than standard ivermectin in most contexts currently. Where ivermectin resistance is suspected, consultation with a veterinary parasitologist is recommended to confirm the resistance pattern and select alternative treatment strategies, including organophosphate dips as an alternative mode of action.

No commercially available vaccine for Psoroptes ovis sheep scab is currently available, though research into vaccine development has been ongoing for several decades. Candidate antigens derived from P. ovis gut proteins have shown partial protection in trial conditions — a 'hidden antigen' approach similar to tick vaccines — but none has reached commercial licensing. Current control relies entirely on antiparasitic treatment (macrocyclic lactones, organophosphate dips) and biosecurity measures to prevent infestation introduction. A successful sheep scab vaccine would be a significant advance for sheep welfare and farm biosecurity management, particularly given the growing concerns about macrocyclic lactone resistance.